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Antibodies against influenza viruses were detected in
115 serum samples from indigenous Mayan persons from
Kochol, Yucatán. Seropositivity rates were 26.9% to
A/Bayern/7/95, 40.8% to A/Sydney/5/97, 1.7% to A/Swine/
Wisconsin/238/97, and 79.1% to A/Swine/Minnesota/
593/99. This report is the first in Mexico of the prevalence
of antibodies to swine influenza virus in humans.
I
nfluenza virus type A has the capacity to infect humans,
birds, swine, and other animals. Studies have repeatedly
shown that influenza virus can move from 1 species to
another. The pig has been proposed as an animal that could
play a key intermediary role in interspecies transmission.
Pigs are the only domesticated mammalian species that are
reared in abundance and are susceptible to both avian and
human influenza virus and allow productive viral replica-
tion (1,2).
In rural zones in the Mexican state of Yucatán, the
“backyard system,” a production system in which animals
such as pigs, ducks, turkeys, and chickens are all raised in
close proximity to humans, is common. This system is a
traditional activity of indigenous Mayan persons, as well
as other ethnic groups in Mexico, and provides an econom-
ical way to produce animals. The animals eat, live, and
share space, water sources, and even food with humans;
they may even be found inside houses. These activities cre-
ate health concerns because of potential for the adaptation
and reassortment of human and avian viruses.
Despite abundant evidence supporting interspecific
transmission and genetic reassortment of influenza virus
around the world, little is known about the influenza virus
in humans and domesticated animals in Yucatán in south-
eastern Mexico. We describe serologic evidence of anti-
bodies against influenza strains from humans and pigs in
indigenous Mayan persons from Yucatán.
The Study
Kochol is located in east Yucatán, ≈20 km from the
municipality of Maxcanu. The 1,207 residents are mostly
dedicated to agricultural activities (3). The population has
high illiteracy rates, poor environmental health, and
crowded and inadequate housing. In Kochol, pigs are
found around the town, walking in and out of houses. All
pigs are wild or criollos. Some families have 1–18 pigs.
For this study, serum samples from 115 persons were made
available by the health official of Kochol in 2000. Serum
samples were from Kochol residents who came to the
health service for any medical condition and required lab-
oratory tests.
Samples were treated with receptor-destroying enzyme
from Vibrio cholera and heated at 56°C in a water bath to
inactivate nonspecific inhibitors (4). The following 4
influenza strains were used to detect antibodies:
A/Swine/Wisconsin/238/97 (classical swine H1N1),
A/Bayern/7/95 (human H1N1), A/Sydney/5/97 (human
H3N2), and A/Swine/Minnesota/593/99 (reassortant swine
H3N2); all were grown in 10-day-old embryonated chick-
en eggs. The hemagglutination inhibition tests were per-
formed by using chicken erythrocytes at a concentration of
0.5%. Asample was considered seropositive to H1 and H3
when the HAtiter was >1:40. Each serum sample was test-
ed against chicken receptor–destroying enzymes in the
absence of virus to rule out induction of nonspecific
hemagglutination. 
Conclusions
As shown in Table 1, reactivity rates were uniformly
high to H3 subtype influenza virus. These results agree
with previous serologic tests of human serum samples
from Yucatán (G. Ayora-Talavera, unpub. data). H1 viruses
likely circulate at a lower frequency than H3 viruses.
Overall, 31 (26.9%) of 115 samples were positive to H1,
whereas 93 (80.8%) of 115 were seropositive to H3. The
results indicate that influenza virus infection occurs in a
large proportion of persons in this area. In general,
Mexican persons are not vaccinated, so we can be sure that
the antibodies detected reflect actual infection (5).
Samples were divided into 5 age groups (Table 2). By ana-
lyzing the percentage of seropositive persons in different
age groups, we observed that persons 15–24 years of age
were most commonly seropositive. Through virus surveil-
lance in Yucatán, we have also observed a very low circu-
lation of influenza A H1. From ≈1,500 throat swabs
collected in 5 years, no sample has been found to contain
H1 influenza by immunofluorescence assay, and only 5
viruses have been detected with reverse
transcription–polymerase chain reaction (G. Ayora-
Talavera, unpub. data).
The highest seropositivity rates across all age groups
were detected with the A/Sw/Minnesota virus as antigen.
Although this strain was isolated from American pigs, the
HA, NA, and PB1 genes are of human origin (6). Taking
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itivity to the swine H1 virus was only detected in 2 sam-
ples, from persons 43 and 59 years of age. However, lower
titers were detected in 4 more persons 33–55 years of age.
The weak reactivity to this virus could suggest a past expo-
sure of adult persons to viruses of swine origin, a situation
that has not occurred in persons >30 years of age. 
The animal population owned by persons in this study
consisted of pigs (68.7%), chickens (73%), and ducks
(17.3%). Any combination of 2 or 3 species was kept by
54.7%. The range of the number of animals owned was
0–12 (mean 2.9) pigs, 0–60 (mean 7) chickens, and 0–23
(mean 0.93) ducks. Since we did not have avian antigens
available, serum samples collected from humans, pigs,
chickens, and ducks were not tested for exposure to avian
influenza viruses.
The relative risk of being seropositive for H1 or H3
viruses from exposure to pigs was 1.93 with human H1
(95% confidence interval [CI] 1.2–3.0), 0.88 with human
H3 (95% CI 0.55–1.4), 0.6 with swine H1 (95% CI
0.08–4.2), and 1.0 with swine H3 (95% CI 0.62–1.6). 
Serologic evidence of swine antibodies in persons in
contact with pigs has been reported in several studies
(7–12). In Mexico, apart from this report, no information
about the prevalence of antibodies to swine influenza virus
in humans exists. The only information available comes
from a study carried out on pig farms in central Mexico,
where the subtype H1 is prevalent in 20% of pigs (13) and
from a previous study from Yucatán, where the most preva-
lent subtype in pig farms is H3 (65%) and H1 (20%) (14). 
As a result of the Mexican outbreak of HPAI H5N2, the
Mexican Ministry of Agriculture (SAGARPA) implement-
ed a national surveillance system in all chicken farms
(NOM-044-ZOO-1995). Yucatán is considered a free state
for avian influenza virus. Chicken farms are sampled 3
times a year for serologic surveillance, and 10% of the
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hand, swine influenza is not considered within the
SAGARPA priorities, and no surveillance program exists
for swine farms, although we found serologic evidence
that in Yucatán influenza H3 subtype is highly prevalent
(14).
Asia has been considered as an epicenter for the gener-
ation of pandemic influenza virus, and some factors are
high densities of humans and animals in close contact (1).
In Yucatán, the backyard system is a common practice, and
human and animal encounters could lead to generation of
novel reassortant viruses here as well.
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